D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 67 Citations 11,772 140 World Ranking 1434 National Ranking 630

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Fungus
  • Microbiology

Annette W. Fothergill spends much of her time researching Microbiology, Voriconazole, Amphotericin B, Itraconazole and Fluconazole. Her research on Microbiology frequently links to adjacent areas such as Aspergillosis. Her Voriconazole research focuses on Posaconazole in particular.

Her work carried out in the field of Amphotericin B brings together such families of science as In vitro and Fusarium. The Itraconazole study combines topics in areas such as Trichophyton, Trichophyton rubrum and Pharmacology. The concepts of her Fluconazole study are interwoven with issues in Amphotéricine B, Amfotericina B, Candida albicans, Mycosis and Dimorphic fungus.

Her most cited work include:

  • Infections Caused by Scedosporium spp. (498 citations)
  • In Vitro Activities of Posaconazole, Itraconazole, Voriconazole, Amphotericin B, and Fluconazole against 37 Clinical Isolates of Zygomycetes (292 citations)
  • MOLECULAR PHYLOGENETIC DIVERSITY, MULTILOCUS HAPLOTYPE NOMENCLATURE, AND IN VITRO ANTIFUNGAL RESISTANCE WITHIN THE FUSARIUM SOLANI SPECIES COMPLEX (290 citations)

What are the main themes of her work throughout her whole career to date?

Microbiology, Fluconazole, Voriconazole, Amphotericin B and Pharmacology are her primary areas of study. Her Microbiology research focuses on In vitro and how it connects with In vivo. She has included themes like Minimum inhibitory concentration, Fungi imperfecti, Mycosis and Candida albicans in her Fluconazole study.

Her Voriconazole research is multidisciplinary, incorporating elements of Murine model, Aspergillus fumigatus, Aspergillosis and Drug resistance. Her study focuses on the intersection of Amphotericin B and fields such as Itraconazole with connections in the field of Ketoconazole and Phaeohyphomycosis. Her Pharmacology research includes elements of Pharmacotherapy, Potency, Terbinafine and Dermatophyte.

She most often published in these fields:

  • Microbiology (66.44%)
  • Fluconazole (28.86%)
  • Voriconazole (28.19%)

What were the highlights of her more recent work (between 2011-2018)?

  • Microbiology (66.44%)
  • In vitro (17.45%)
  • Pharmacology (22.82%)

In recent papers she was focusing on the following fields of study:

The scientist’s investigation covers issues in Microbiology, In vitro, Pharmacology, Voriconazole and In vivo. Caspofungin, Broth microdilution, Amphotericin B, Fluconazole and Corpus albicans are subfields of Microbiology in which her conducts study. Her Fluconazole research focuses on Cryptococcus neoformans and how it relates to Intensive care medicine and Treatment decision making.

Her Pharmacology research integrates issues from Antifungal, Potency, Terbinafine and Candida albicans. Her biological study focuses on Posaconazole. The study incorporates disciplines such as Candida glabrata, Echinocandin and Cryptococcosis in addition to In vivo.

Between 2011 and 2018, her most popular works were:

  • First Detection of TR34 L98H and TR46 Y121F T289A Cyp51 Mutations in Aspergillus fumigatus Isolates in the United States (104 citations)
  • Antifungal Susceptibility Testing: Clinical Laboratory and Standards Institute (CLSI) Methods (99 citations)
  • Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B, Flucytosine, and Itraconazole and Candida spp. as Determined by CLSI Broth Microdilution (95 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Fungus
  • Microbiology

Annette W. Fothergill focuses on Microbiology, Itraconazole, Voriconazole, Pharmacology and Azole. Her Microbiology research incorporates elements of In vitro and Fungus. Her work in Itraconazole addresses issues such as Amphotericin B, which are connected to fields such as Corpus albicans and Broth microdilution.

Her studies deal with areas such as Antifungal drug and Surgery as well as Voriconazole. Her Azole research is multidisciplinary, relying on both Aspergillus fumigatus and Aspergillosis. Her studies in Fluconazole integrate themes in fields like Cryptococcus gattii and Candida glabrata.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Infections Caused by Scedosporium spp.

Karoll J. Cortez;Emmanuel Roilides;Flavio Quiroz-Telles;Joseph Meletiadis.
Clinical Microbiology Reviews (2008)

681 Citations

Fungal rhinosinusitis: A categorization and definitional schema addressing current controversies

Arunaloke Chakrabarti;David W. Denning;Berrylin J. Ferguson;Jens Ponikau.
Laryngoscope (2009)

496 Citations

MOLECULAR PHYLOGENETIC DIVERSITY, MULTILOCUS HAPLOTYPE NOMENCLATURE, AND IN VITRO ANTIFUNGAL RESISTANCE WITHIN THE FUSARIUM SOLANI SPECIES COMPLEX

Kerry O'Donnell;Deanna A. Sutton;Annette Fothergill;Dora McCarthy.
Journal of Clinical Microbiology (2008)

456 Citations

Guide to Clinically Significant Fungi

Deanna A. Sutton;Annette W. Fothergill;Michael G. Rinaldi.
(1998)

432 Citations

In Vitro Activities of Posaconazole, Itraconazole, Voriconazole, Amphotericin B, and Fluconazole against 37 Clinical Isolates of Zygomycetes

Qiu N. Sun;Annette W. Fothergill;Dora I. McCarthy;Michael G. Rinaldi;Michael G. Rinaldi.
Antimicrobial Agents and Chemotherapy (2002)

423 Citations

Resistance of Candida albicans to Fluconazole During Treatment of Oropharyngeal Candidiasis in a Patient with AIDS: Documentation by In Vitro Susceptibility Testing and DNA Subtype Analysis

S. Redding;J. Smith;J. Smith;G. Farinacci;G. Farinacci;M. Rinaldi;M. Rinaldi.
Clinical Infectious Diseases (1994)

382 Citations

In Vitro Amphotericin B Resistance in Clinical Isolates of Aspergillus terreus, with a Head-to-Head Comparison to Voriconazole

Deanna A. Sutton;Stephen E. Sanche;Sanjay G. Revankar;Annette W. Fothergill.
Journal of Clinical Microbiology (1999)

315 Citations

In Vitro Susceptibilities of 217 Clinical Isolates of Zygomycetes to Conventional and New Antifungal Agents

Nikolaos G. Almyroudis;Deanna A. Sutton;Annette W. Fothergill;Michael G. Rinaldi.
Antimicrobial Agents and Chemotherapy (2007)

306 Citations

Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi.

A. Espinel-Ingroff;M. Bartlett;R. Bowden;N. X. Chin.
Journal of Clinical Microbiology (1997)

277 Citations

Detection of Candida dubliniensis in Oropharyngeal Samples from Human Immunodeficiency Virus-Infected Patients in North America by Primary CHROMagar Candida Screening and Susceptibility Testing of Isolates

William R. Kirkpatrick;Sanjay G. Revankar;Robert K. Mcatee;Jose L. Lopez-Ribot.
Journal of Clinical Microbiology (1998)

274 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Annette W. Fothergill

Thomas J. Walsh

Thomas J. Walsh

Weill Cornell Medicine

Publications: 133

Josep Guarro

Josep Guarro

Rovira i Virgili University

Publications: 111

Jacques F. Meis

Jacques F. Meis

Canisius-Wilhelmina Ziekenhuis

Publications: 105

Thomas F. Patterson

Thomas F. Patterson

The University of Texas Health Science Center at San Antonio

Publications: 100

Nathan P. Wiederhold

Nathan P. Wiederhold

The University of Texas Health Science Center at San Antonio

Publications: 97

Paul E. Verweij

Paul E. Verweij

Radboud University Nijmegen

Publications: 90

Michael A. Pfaller

Michael A. Pfaller

JMI Laboratories

Publications: 82

Manuel Cuenca-Estrella

Manuel Cuenca-Estrella

Instituto de Salud Carlos III

Publications: 68

Sharon C.-A. Chen

Sharon C.-A. Chen

University of Sydney

Publications: 68

Dimitrios P. Kontoyiannis

Dimitrios P. Kontoyiannis

The University of Texas MD Anderson Cancer Center

Publications: 66

Deanna A. Sutton

Deanna A. Sutton

The University of Texas Health Science Center at San Antonio

Publications: 64

Shawn A. Messer

Shawn A. Messer

JMI Laboratories

Publications: 64

Michael G. Rinaldi

Michael G. Rinaldi

The University of Texas Health Science Center at San Antonio

Publications: 60

Ana Espinel-Ingroff

Ana Espinel-Ingroff

Virginia Commonwealth University Medical Center

Publications: 54

Eric Dannaoui

Eric Dannaoui

Université Paris Cité

Publications: 54

Emmanuel Roilides

Emmanuel Roilides

Aristotle University of Thessaloniki

Publications: 53

Trending Scientists

Yong Man Ro

Yong Man Ro

Korea Advanced Institute of Science and Technology

George Sperling

George Sperling

University of California, Irvine

Junsheng Yu

Junsheng Yu

University of Electronic Science and Technology of China

Moonyong Lee

Moonyong Lee

Yeungnam University

John G. Kirkwood

John G. Kirkwood

Yale University

Ivan Infante

Ivan Infante

Italian Institute of Technology

Norio Nishi

Norio Nishi

Hokkaido University

Elena Levi

Elena Levi

Bar-Ilan University

Rebecca Schüle

Rebecca Schüle

University of Tübingen

Masao Ota

Masao Ota

Shinshu University

Keiko Nakayama

Keiko Nakayama

Tohoku University

Robert A. Holman

Robert A. Holman

Oregon State University

Pasquale P. C. Graziadei

Pasquale P. C. Graziadei

Florida State University

Mark J. Martinko

Mark J. Martinko

Florida State University

David Sugden

David Sugden

University of Leeds

Michael C. Monuteaux

Michael C. Monuteaux

Boston Children's Hospital

Something went wrong. Please try again later.